Cirrhosis/Liver Failure News

The United Network for Organ Sharing database on acute-on-chronic liver failure categorization in liver transplant patients is discordant with manual chart review and demonstrates the need for policy reform, according to study results.

Increased levels of vitamin D may prevent nonalcoholic fatty liver disease among European populations, according to research published in Clinical Gastroenterology and Hepatology.

Patients with alcohol-associated cirrhosis had higher mortality following ICU discharge compared with patients with cirrhosis related to other causes, according to study results published in Mayo Clinic Proceedings.

Many individuals look to the new year to follow through their resolutions such as diet and exercise and some are now attempting ‘Dry January’, to reset after a holiday full of drinking.

Nearly 80% of U.S. adults with obesity and diabetes have hepatic steatosis and an increased risk for advanced fibrosis, according to study findings published in Obesity.

In this Healio Gastroenterology video exclusive, Arun J. Sanyal, MD, professor of medicine at Virginia Commonwealth University, discussed real-world data on patient characteristics, treatment and clinical response in hepatorenal syndrome.

Providers should closely monitor people with diabetes and other high-risk adults for nonalcoholic fatty liver disease and consider multiple noninvasive tests to detect the presence of advanced fibrosis, according to a speaker.

Children with obesity and a high level of liver fat content are more likely to have impaired glucose tolerance, prediabetes and type 2 diabetes compared with those with normal liver fat content, according to a speaker

VBI Vaccines announced that the FDA has approved the company’s recombinant trivalent hepatitis B vaccine, PreHevbrio, for adults aged 18 years or older.

Healio Gastroenterology and Hepatology presents the following report on highlights from The Liver Meeting Digital Experience.